Suture Fixation Versus Tension Band Wiring of Simple Displaced Olecranon Fractures

December 5, 2019 updated by: Andreas Haubjerg Qvist, Aalborg University Hospital
Simple displaced olecranon fractures are most often treated with tension band wiring. This is an effective treatment, but the risk of subsequent re-operation is high. The investigators propose open reduction and internal fixation with a strong suture, thus reducing the risk of re-operation significantly.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Background Olecranon fractures are frequent with an incidence of 11.5 per 100.000 people per year. Olecranon fractures are classified according to the Mayo classification in three groups. Type 1A and B are treated conservatively, while comminute fractures of type Mayo 2B and 3B are treated with plate osteosynthesis.

The most common type is a simple two part fracture, Mayo type 2A, which represents 74% of all olecranon fractures. The typical treatment of Mayo type 2A fractures is osteosynthesis using k-wires and tension band wiring. This provides adequate fracture healing and good functional results. The use of plate osteosynthesis for Mayo type 2A fractures does not provide functional or health economic benefits compared with operation with tension band wiring.

Common for both techniques is a high risk of re-operation due to delayed healing of the surgical wound, and complications arising from the implanted material.

Recently, new techniques for Mayo type 2A fractures have been described, in which no metal is implanted. Osteosynthesis is achieved with strong sutures. These techniques have been shown to reduce the high risk of complications leading to re-operation without effecting the functional outcome or fracture healing rate.

Hypothesis The investigators hypothesize that suture fixation of Mayo type 2A fractures will decrease the risk of re-operation and provide equal functional outcome compared with tension band wiring.

Design Prospective, randomized multicenter study

Study Type

Interventional

Enrollment (Anticipated)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Bjørn Christensen, MD, PhD
  • Phone Number: +4522449180
  • Email: bjornbc@gmail.com

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Olecranon fracture, Mayo Type 2A

Exclusion Criteria:

  • Bilateral upper extremity fracture
  • Open fracture
  • Neurovascular affection
  • Injury to ligament, dislocation or subluxation
  • Additional upper extremity fracture
  • Pathological fracture
  • Previous elbow issue
  • Fracture more than 14 days old
  • Substance abuse
  • medical contraindication for surgery
  • Previous fracture to the same elbow

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: K-wire tension band wiring
The patient is treated with 1.6 mm k-wires and 1 mm cerclage
The fracture is reduced. A 2.5 mm hole is drilled in the dorsal olecranon 15mm from the fracture. A suture is passed through the hole and is fixed to the triceps muscle. A second suture is fixed to the triceps muscle in a figure 8 configuration.
Active Comparator: Suture fixation
The fracture is reduced and fixed with 2.0 Orthocord suture.
The fracture is reduced. A 2.5 mm hole is drilled in the dorsal olecranon 15mm from the fracture. A suture is passed through the hole and is fixed to the triceps muscle. A second suture is fixed to the triceps muscle in a figure 8 configuration.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Re-operation
Time Frame: 1 year
The rate of re-operation
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Disabilities of the Arm, Shoulder and Hand (DASH) Score
Time Frame: 1 year
Patient reported outcome measure. Range from 0 (No disability) to 100 (most severe disability).
1 year
European Quality of life - 5 Dimensions (EQ-5D) questionnaire
Time Frame: 1 year
Patient reported outcome measure. Score from 1 (best) to 3 (worst) in 5 different categories.
1 year
Range of motion
Time Frame: 1 year
Range of motion in elbow
1 year
Sick days
Time Frame: 1 year
Number of sick days/Return to work
1 year
Non-union
Time Frame: 6 months
Rate of non-union
6 months
Rate of complications
Time Frame: 1 year
Rate of complications to the treatment: Infection, nerve damage, delayed wound healing.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andreas Qvist, MD, Aalborg University Hostipital
  • Principal Investigator: Andreas Haubjerg Qvist, MD, Aalborg University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 5, 2019

Primary Completion (Anticipated)

November 20, 2021

Study Completion (Anticipated)

November 20, 2023

Study Registration Dates

First Submitted

November 19, 2019

First Submitted That Met QC Criteria

December 5, 2019

First Posted (Actual)

December 6, 2019

Study Record Updates

Last Update Posted (Actual)

December 6, 2019

Last Update Submitted That Met QC Criteria

December 5, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 20190039

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Olecranon Fracture

Clinical Trials on Suture fixation

3
Subscribe